Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease
Authors:
- 1 November 2014
- journal article
- case report
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 8 (11) , 1551-1556
Abstract
Defects in the interleukin 10 (IL-10) signalling pathway have been shown to cause very early onset inflammatory bowel disease (IBD). We report a patient with severe infantile-onset IBD with a compound heterozygous IL-10 receptor alpha subunit (IL-10RA) mutation, one of which was paternally-inherited and the other occurring de novo. Deep sequencing of IL-10, IL-10RA and IL-10 receptor beta subunit (IL-10RB) were performed. Peripheral blood mononuclear cell (PBMC) surface expression of IL-10RA was analysed by flow cytometry. IL-10 signalling pathway was examined by measuring phosphorylated STAT3 in PBMC cultured in the presence of IL-6 or IL-10. We identified a missense mutation in exon 4 of IL-10RA (c.583T>C) in one allele and a nonsense mutation in exon 7 of IL-10RA (c.1368G>T) in the other allele. Neither mutation has been reported previously. The patient has functional IL-10RA deficiency despite normal IL-10RA expression. This represents the first case report of a de novo mutation of IL-10RA that is associated with very early onset severe IBD. Therefore, IL-10 pathway defect should be considered in patients with infantile-onset IBD even if the parents are non-consanguineous.Keywords
This publication has 17 references indexed in Scilit:
- Clinical outcome in IL-10– and IL-10 receptor–deficient patients with or without hematopoietic stem cell transplantationJournal of Allergy and Clinical Immunology, 2013
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative ColitisInflammatory Bowel Diseases, 2013
- Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and TherapyGastroenterology, 2012
- Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's diseaseGenes & Immunity, 2012
- Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2011
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibilityNature Genetics, 2008
- Interleukin 6: from bench to bedsideNature Clinical Practice Rheumatology, 2006
- Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human MacrophagesThe Journal of Immunology, 2004
- Crystal Structure of the IL-10/IL-10R1 Complex Reveals a Shared Receptor Binding SiteImmunity, 2001